The TABLET trial: results
5th April 2019
The results of the TABLET trial have just been published in the online edition of the New England Journal of Medicine.
Sadly, they show that the use of Levothyroxine did not reduce the risk of miscarriage in women who have thyroid antibodies but who are ‘euthyroid’ – that is, their thyroid hormones are in the normal range (described as euthyroid).
The results also showed that Levothyroxine also did not result in a higher rate of live births beyond 34 weeks.
You can read more about the trial here.
